title: [Prospects for incretin-related drugs].
authors: Division of Diabetes, Clinical Nutrition and Endocrinology, Internal Medicine, Kansai Electric Power Hospital.
authors: Takeshi
authors: T
authors: Kurose
authors: Yutaka
authors: Y
authors: Seino
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use*; D052216:Glucagon-Like Peptide 1 / Q000031:analogs & derivatives*; D006801:Humans; D054795:Incretins / Q000502:physiology; D018027:Receptors, Glucagon / Q000819:agonists*
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors; D054795:Incretins; D018027:Receptors, Glucagon; D052216:Glucagon-Like Peptide 1